Book a Meeting

miRNA Screening Service for Infectious Disease Research

Studying microRNA (miRNA) is of significant importance for uncovering the mechanisms of diseases at the cellular level, especially in the field of infectious disease research. A deep understanding of how miRNAs influence the lifecycle of pathogens and the immune response of hosts is crucial for developing innovative treatment strategies. Creative Biolabs' miRNA screening service can effectively accelerate research progress, aiding scientists in achieving significant results in infectious disease research.

miR-223 physiological function in regulating infectious diseases. (Yuan, et al., 2021)Fig.1 Physiological function of miR-223 and its role in regulating infectious diseases.1,2

Unveiling miRNA: Starting a New Chapter in Infectious Disease Research and Treatment

miRNA is a class of non-coding small RNA molecules, typically ranging in length from 18 to 25 nucleotides. miRNAs play a vital regulatory role in cells, primarily by controlling gene expression at the post-transcriptional level. They bind complementarily to specific sequences of target mRNAs (messenger RNAs), thereby hindering the translation of these mRNAs or promoting their degradation. This unique regulatory mode of miRNAs means they hold great potential in the field of infectious disease research and treatment.

  • Research on Infection Mechanisms:

Host-Pathogen Interaction: miRNAs play a significant role during pathogen infection. Studying specific miRNAs during infection can reveal how hosts and pathogens interact.

Host Cell Response: miRNAs can affect the immune response of host cells to pathogens. For example, certain miRNAs may enhance or suppress inflammatory responses, which is crucial for understanding the host's defense mechanisms against infections.

Pathogen Lifecycle: Studying how miRNAs affect the replication and survival of pathogens can help scientists better understand the lifecycle of pathogens and their interactions with host cells.

  • Infectious Disease Treatment Research:

New Drug Targets: miRNAs can serve as new drug targets. By regulating disease-related miRNAs, new treatment strategies can be developed to combat infections.

Treatment Strategy Development: Utilizing the regulatory functions of miRNAs, specific treatment methods for particular infections can be designed, such as using miRNA mimics or inhibitors to modulate host cell responses to pathogen infections.

miRNA Screening Service: A New Weapon in Infectious Disease Research

In the vast field of infectious disease research, Creative Biolabs' miRNA screening service provides a sharp new tool. Through this advanced service, we help researchers explore the critical role of miRNAs in infectious diseases, thereby accelerating the discovery and development of new treatment methods.

Core Service List:

  • Advanced miRNA Synthesis Technology: We can synthesize conventional miRNA mimics, miRNA inhibitors, modified miRNA agomir, modified miRNA antagomir, and pre-miRNA mimic, providing clients with more precise targeting research tools.
  • Extensive miRNA Library Screening: We have built a vast miRNA library, allowing you to conduct extensive screening across various infectious disease models and identify key miRNA targets.
  • Customized miRNA Screening Plans: Tailored to different infectious disease research needs, we offer customized screening plans, including studies on specific pathogen-host interactions.
  • Comprehensive Target Validation Services: We provide not only miRNA screening services but also target validation and functional studies, helping you understand the mechanisms of miRNAs.
  • Advanced Bioinformatics Analysis: Combining the latest bioinformatics tools, we offer deep data analysis and interpretation to ensure the accuracy and reliability of your research results.

Explore the limitless possibilities of miRNAs in infectious disease research and open the door to a new world with Creative Biolabs. Contact us, and let our expert team help you achieve your scientific dreams.

References:

  1. Yuan, S.; et al. miR-223: an immune regulator in infectious disorders. Frontiers in Immunology. 2021, 12:781815.
  2. under Open Access license CC BY 4.0, without modification.
For Research Use Only. We do not provide direct services or products for patients.
Related Services:
Online Inquiry
For Research Use Only. We do not provide direct services or products for patients.

Contact Us
Contact Us
  • (USA)
    (UK)
    (Germany)
  • Global Locations